Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes.
Adult rat cardiomyocytes in long-term culture express type 1 insulin-like growth factor (IGF) receptors. In contrast to insulin receptors, type 1 IGF receptors are up-regulated during culturing. IGF-I added to the cells at plating increased granular density and pseudopodia number per cell after 7 days. After 16 days, IGF-I-treated cells showed, as compared with controls, a dramatic increase of the number of newly built sarcomeres and were packed with myofibrils. At the same time, IGF-I suppressed the accumulation of smooth muscle alpha-actin (sm-alpha-actin) in a dose-dependent manner. Under the conditions of this in vitro system, growth hormone had no effect on cell morphology or sm-alpha-actin. sm-alpha-Actin, a nonsarcomeric isoform of actin expressed in early fetal cardiac development, reappears both during long-term culture of adult rat cardiomyocytes and during heart hypertrophy. This study shows that type 1 IGF receptors are up-regulated in adult rat cardiomyocytes in long-term culture and that IGF-I enhances myofibril development and concomitantly down-regulates sm-alpha-actin. This protein forms stress-fiber-like structures and may temporarily serve as a scaffold for the formation of new sarcomeres until myofibrils have developed throughout the cell and the scaffold is no longer needed. Our findings thus allow us to propose another hypothesis for the mechanism leading to overload heart hypertrophy.
Donath
M Y
MY
Department of Medicine, University Hospital, Zurich, Switzerland.
Zapf
J
J
Eppenberger-Eberhardt
M
M
Froesch
E R
ER
Eppenberger
H M
HM
D000199:Actins / Q000378:metabolism*; D000818:Animals; D006332:Cardiomegaly / Q000209:etiology; D002478:Cells, Cultured; D006321:Heart / Q000187:drug effects*; D007334:Insulin-Like Growth Factor I / Q000378:metabolism / Q000494:pharmacology*; D007700:Kinetics; D009206:Myocardium / Q000166:cytology* / Q000378:metabolism*; D051381:Rats; D017526:Receptor, IGF Type 1 / Q000187:drug effects / Q000378:metabolism; D012518:Sarcomeres / Q000187:drug effects / Q000648:ultrastructure; D015854:Up-Regulation
D000199:Actins; D007334:Insulin-Like Growth Factor I; D017526:Receptor, IGF Type 1